Chitosan-modified cholesterol-free liposomes for improving the oral bioavailability of progesterone

Colloids and Surfaces B: Biointerfaces

Volumn 159, Issue , 2017, Pages 580-585

  Wang, Mei ^a   Liu, Meng ^a   Xie, Tingting ^c   Zhang, Bing Feng ^b   Gao, Xiao Li ^a  

^a XINJIANG MEDICAL UNIVERSITY   (China)

^b YICHUN UNIVERSITY   (China)

^c CHINESE PLA GENERAL HOSPITAL   (China)

Author keywords

Chitosan; Cholesterol free liposomes; Oral bioavailability; Progesterone

Indexed keywords

BIOCHEMISTRY; CHITOSAN; CONTROLLED DRUG DELIVERY; LIPOSOMES; TARGETED DRUG DELIVERY;

DRUG ENTRAPMENT; GASTROINTESTINAL TRACT; ORAL ADMINISTRATION; ORAL BIOAVAILABILITIES; POSITIVE POTENTIAL; PROGESTERONE; RELATIVE BIOAVAILABILITY; SUSTAINED RELEASE;

CHOLESTEROL;

CHITOSAN; LIPOSOME; PROGESTERONE; CHOLESTEROL;

ANIMAL EXPERIMENT; ANIMAL TISSUE; AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG CAPSULE; DRUG DEGRADATION; DRUG DOSAGE FORM COMPARISON; DRUG PENETRATION; DRUG RELEASE; DRUG STABILITY; ENCAPSULATION; EX VIVO STUDY; FEMALE; IN VITRO STUDY; LIPOSOMAL DELIVERY; MOUSE; NONHUMAN; PARTICLE SIZE; PRIORITY JOURNAL; STOMACH JUICE; ZETA POTENTIAL; ANIMAL; CHEMISTRY; GASTROINTESTINAL TRACT; METABOLISM;

ANIMALS; CHITOSAN; CHOLESTEROL; GASTROINTESTINAL TRACT; LIPOSOMES; MICE; PROGESTERONE;

EID: 85028355341     PISSN: 09277765     EISSN: 18734367     Source Type: Journal    
DOI: 10.1016/j.colsurfb.2017.08.028     Document Type: Article

References (26)

1. Al-Asmakh, M., Reproductive functions of progesterone. Middle East Fertil. Soc. J., 12, 2007, 147.
2. Sun, Y., Cai, J., Ma, F., Lu, P., Huang, H., Zhou, J., miR-155 mediates suppressive effect of progesterone on TLR3, TLR4-triggered immune response. Immunol. Lett. 146 (2012), 25–30.
3. Zhao, X., Liu, L., Liu, D., Fan, H., Wang, Y., Hu, Y., Hou, Y., Progesterone enhances immunoregulatory activity of human mesenchymal stem cells via PGE2 and IL-6. Am. J. Reprod. Immunol. 68 (2012), 290–300.
4. Lahiani-Skiba, M., Barbot, C., Bounoure, F., Joudieh, S., Skiba, M., Solubility and dissolution rate of progesterone-cyclodextrin-polymer systems. Drug Dev. Ind. Pharm. 32 (2006), 1043–1058.
5. Jain, S.K., Singh, R., Sahu, B., Development of a liposome based contraceptive system for intravaginal administration of progesterone. Drug Dev. Ind. Pharm. 23 (1997), 827–830.
6. Potluri, P., Betageri, G.V., Mixed-micellar proliposomal systems for enhanced oral delivery of progesterone. Drug Deliv. 13 (2006), 227–232.
7. Abboud, R., Greige-Gerges, H., Charcosset, C., Effect of progesterone, its hydroxylated and methylated derivatives, and dydrogesterone on lipid bilayer membranes. J. Membr. Biol. 248 (2015), 811–824.
8. Carlson, J.C., Gruber, M.Y., Thompson, J.E., A study of the interaction between progesterone and membrane lipids. Endocrinology 113 (1983), 190–194.
9. Dos Santos, N., Mayer, L.D., Abraham, S.A., Gallagher, R.C., Cox, R.A.K., Tardi, P.G., Bally, M.B., Improved retention of idarubicin after intravenous injection obtained for cholesterol-free liposomes. Biochim. Biophys. Acta 1561 (2002), 188–201.
10. Hou, J., Sun, E., Sun, C., Wang, J., Yang, L., Jia, X.-b., Zhang, Z.-h., Improved oral bioavailability and anticancer efficacy on breast cancer of paclitaxel via Novel Soluplus (R)-Solutol (R) HS15 binary mixed micelles system. Int. J. Pharm. 512 (2016), 186–193.
11. Ali Khan, A., Mudassir, J., Mohtar, N., Darwis, Y., Advanced drug delivery to the lymphatic system: lipid-based nanoformulations. Int. J. Nanomed. 8 (2013), 2733–2744.
12. Ahn, H., Park, J.-H., Liposomal delivery systems for intestinal lymphatic drug transport. Biomater. Res., 20, 2016 36–36.
13. Caddeo, C., Pons, R., Carbone, C., Fernandez-Busquets, X., Cristina Cardia, M., Maria Maccioni, A., Maria Fadda, A., Manconi, M., Physico-chemical characterization of succinyl chitosan-stabilized liposomes for the oral co-delivery of quercetin and resveratrol. Carbohydr. Polym. 157 (2017), 1853–1861.
14. Chen, H., Pan, H., Li, P., Wang, H., Wang, X., Pan, W., Yuan, Y., The potential use of novel chitosan-coated deformable liposomes in an ocular drug delivery system. Colloids Surf. B Biointerfaces 143 (2016), 455–462.
15. Yang, Z., Liu, J., Gao, J., Chen, S., Huang, G., Chitosan coated vancomycin hydrochloride liposomes: characterizations and evaluation. Int. J. Pharm. 495 (2015), 508–515.
16. Takeuchi, H., Thongborisute, J., Matsui, Y., Sugihara, H., Yamamoto, H., Kawashima, Y., Novel mucoadhesion tests for polymers and polymer-coated particles to design optimal mucoadhesive drug delivery systems. Adv. Drug Deliv. Rev. 57 (2005), 1583–1594.
17. Huang, A., Makhlof, A., Ping, Q., Tozuka, Y., Takeuchi, H., N-Trimethyl chitosan-modified liposomes as carriers for oral delivery of salmon calcitonin. Drug Deliv. 18 (2011), 562–569.
18. Wang, M., Xie, T., Chang, Z., Wang, L., Xie, X., Kou, Y., Xu, H., Gao, X., A new type of liquid silymarin proliposome containing bile salts: its preparation and improved hepatoprotective effects. PLoS One, 10, 2015, e0143625.
19. Iwanaga, K., Ono, S., Narioka, K., Kakemi, M., Morimoto, K., Yamashita, S., Namba, Y., Oku, N., Application of surface-coated liposomes for oral delivery of peptide: effects of coating the liposome's surface on the GI transit of insulin. J. Pharm. Sci. 88 (1999), 248–252.
20. Bharate, S.S., Bharate, S.B., Bajaj, A.N., Incompatibilities of pharmaceutical excipients with active pharmaceutical ingredients: a comprehensive review. J. Excip. Food Chem. 1 (2010), 3–26.
21. Healy, A., McDonald, B., Tajber, L., Corrigan, O., Characterisation of excipient-free nanoporous microparticles (NPMPs) of bendroflumethiazide. Eur. J. Pharm. Biopharm. 69 (2008), 1182–1186.
22. Hu, S., Lee, E., Wang, C., Wang, J., Zhou, Z., Li, Y., Li, X., Tang, J., Lee, D.H., Liu, X., Amphiphilic drugs as surfactants to fabricate excipient-free stable nanodispersions of hydrophobic drugs for cancer chemotherapy. J. Control. Release 220 (2015), 175–179.
23. Woitiski, C.B., Sarmento, B., Carvalho, R.A., Neufeld, R.J., Veiga, F., Facilitated nanoscale delivery of insulin across intestinal membrane models. Int. J. Pharm. 412 (2011), 123–131.
24. Wu, W., Lu, Y., Qi, J., Oral delivery of liposomes. Ther. Deliv. 6:11 (2015), 1239–1241.
25. Niu, M., Tan, Y., Guan, P., Hovgaard, L., Lu, Y., Qi, J., Lian, R., Li, X., Wu, W., Enhanced oral absorption of insulin-loaded liposomes containing bile salts: a mechanistic study. Int. J. Pharm. 460 (2014), 119–130.
26. Niu, M., Lu, Y., Hovgaard, L., Guan, P., Nan, Y., Lian, R., Qi, J., Wu, W., Hypoglycemic activity and oral bioavailability of insulin-loaded liposomes containing bile salts in rats: the effect of cholate type particle size and administered dose. Eur. J. Pharm. Biopharm. 81 (2012), 265–272.